COLA Mass Spec Criteria

Similar documents
QUALITY CONTROL CRITERIA FOR CHEMISTRY EXCEPT RADIOCHEMISTRY.

The Theory of HPLC. Quantitative and Qualitative HPLC

Copyright ENCO Laboratories, Inc. II. Quality Control. A. Introduction

Understanding the Uncertainty Associated with Analytical Results: Sources, Control and Interpretation of Results. Marc Paquet, Chemist M.Sc.

Introduction to LC-MS

Schedule. Draft Section of Lab Report Monday 6pm (Jan 27) Summary of Paper 2 Monday 2pm (Feb 3)

SWGDRUG GLOSSARY. Independent science-based organization that has the authority to grant

Perfluorinated Alkyl Acids (PFAA) in Water by LC/MS/MS - PBM

LC-MS/MS in the Clinical Laboratory. Jo Adaway

Objectives. Concepts in Quality Control Data Management. At the conclusion, the participant should be able to:

Evaluation of a New HPLC, a New Tandem MS and a New Data Processing Software for General Clinical Use

3.1.1 The method can detect, identify, and potentially measure the amount of (quantify) an analyte(s):

Quantitation and Ratio Determination of Uranium Isotopes in Water and Soil Using Inductively Coupled Plasma Mass Spectrometry (ICP-MS)

Method Validation Characteristics through Statistical Analysis Approaches. Jane Weitzel

Rapid Screening and Confirmation of Melamine Residues in Milk and Its Products by Liquid Chromatography Tandem Mass Spectrometry

Review and Reporting of Chemical of Concern (COC) Concentration Data Under the TRRP Rule (30 TAC 350)

High-Throughput LC-MS/MS Quantification of Estrone (E1) and Estradiol (E2) in Human Blood Plasma/Serum for Clinical Research Purposes

Method Validation and Accreditation

BIOANALYTICAL METHOD VALIDATION M10

VALIDATION OF A UPLC METHOD FOR A BENZOCAINE, BUTAMBEN, AND TETRACAINE HYDROCHLORIDE TOPICAL SOLUTION

Assay Transfer from HPLC to UPLC for Higher Analysis Throughput

Isotope Dilution Mass Spectrometry

Verification and Review of Data for Chlorinated Dioxins, Furans and PCB Congeners by Isotope Dilution HRGC/ HRMS

Determination of Hormones in Drinking Water by LC/MS/MS Using an Agilent InfinityLab Poroshell HPH Column (EPA 539)

Quantitative analysis of small molecules in biological samples. Jeevan Prasain, Ph.D. Department of Pharmacology & Toxicology, UAB.

Tips & Tricks GPC/SEC: Quantify and Get More Than Molar Mass Averages

Laboratory 101: A Guide to Understanding your Testing Laboratory

Verification of LOD and LOQ according to the NELAC and TNI Standards

LC/MS/MS qua ntitation of β-estradiol 17-acetate using an Agilent 6460 Triple Quadrupole LC/MS working in ESI negative ion mode

Analytical Methods Validation

Validation of analytical methods. Adrian Covaci Toxicological Center, University of Antwerp

Pittcon P

ELISA QUALITY ASSURANCE Analytical Phase

PCB Congener Analysis of XAD-2 Resins and GFF Filters Using GC/ECD

Quantitative Analysis of EtG and EtS in Urine Using FASt ETG and LC-MS/MS

METHOD 8033 ACETONITRILE BY GAS CHROMATOGRAPHY WITH NITROGEN-PHOSPHORUS DETECTION

Quantitative Analysis of EtG and EtS in Urine Using FASt ETG and LC-MS/MS

Signal, Noise, and Detection Limits in Mass Spectrometry

Guide to Peptide Quantitation. Agilent clinical research

QSM 5.1 FAQs. For a test with a recommended maximum holding time measured in hours, the holding time shall be tracked by the hour.

Uncertainty of Measurement

Method Validation. Role of Validation. Two levels. Flow of method validation. Method selection

OF ANALYSIS FOR DETERMINATION OF PESTICIDES RESIDUES IN FOOD (CX/PR 15/47/10) European Union Competence European Union Vote

Draft Guideline on Bioanalytical Method Validation in. Pharmaceutical Development. (15 April 2013, MHLW, Japan)

IN THE CIRCUIT COURT OF THE SEVENTEENTH JUDICIAL CIRCUIT IN AND FOR BROWARD COUNTY, FLORIDA. Div.: XXXXXXXX PRC MOTION TO COMPEL ADDITIONAL DISCOVERY

Introduction to E&Ls 1

WADA Technical Document TD2015IDCR

Analysis of Serum 17-Hydroxyprogesterone, Androstenedione, and Cortisol by UPLC-MS/MS for Clinical Research

Tackling Statistical Uncertainty in Method Validation

ASEAN GUIDELINES FOR VALIDATION OF ANALYTICAL PROCEDURES

EPA Method 535: Detection of Degradates of Chloroacetanilides and other Acetamide Herbicides in Water by LC/MS/MS

Validation of an Analytical Method

Part IVB Quality Assurance/Validation of Analytical Methods

Laboratory Quality Control Report: Why is it Important?

WADA Technical Document TD2003IDCR

Gentian Canine CRP Immunoassay Application Note for ABX Pentra * 400

Proposed Procedures for Determining the Method Detection Limit and Minimum Level

EPA Method 535: Detection of Degradates of Chloroacetanilides and other Acetamide Herbicides in Water by LC/MS/MS

OBJECTIVE DATA PACKAGE DELIVERABLES

A Study of Stability, Robustness and Time Efficiency of a New HPLC and a New Tandem MS

Qualification Code Reference Table Cont.

Test Report. Glava AS. Emission test of Ecophon Venus according to M1 classification. October / November Smedeskovvej 38, DK-8464 Galten

All Ions MS/MS: Targeted Screening and Quantitation Using Agilent TOF and Q-TOF LC/MS Systems

TNI Standard; EL-V1M4 Sections and (Detection and Quantitation) page1 of 8. TNI Standard VOLUME 1 MODULE 4

GUIDELINES ON PERFORMANCE CRITERIA FOR METHODS OF ANALYSIS FOR THE DETERMINATION OF PESTICIDE RESIDUES IN FOOD AND FEED CXG Adopted in 2017.

Validation and Standardization of (Bio)Analytical Methods

VALIDATION OF ANALYTICAL METHODS. Presented by Dr. A. Suneetha Dept. of Pharm. Analysis Hindu College of Pharmacy

Laboratory Guidelines

STANDARD OPERATING PROCEDURES SOP: 1828 PAGE: 1 of 14 REV: 0.0 DATE: 05/12/95 ANALYSIS OF METHYL PARATHION IN CARPET SAMPLES BY GC/MS

PROJECT ID: W09341 LABORATORY REPORT NUMBER: L

Definitive EtG/EtS LC-MS/MS Analysis:

Assessing Test Quality from EQA/PT Surveys. James O. Westgard University of Wisconsin Medical School Sten A. Westgard Westgard QC, Inc.

Increasing Speed of UHPLC-MS Analysis Using Single-stage Orbitrap Mass Spectrometer

Multi-residue analysis of pesticides by GC-HRMS

Draft Guideline on Bioanalytical Method (Ligand Binding Assay) Validation in Pharmaceutical Development. (24 January, 2014, MHLW, Japan)

[application note] INTRODUCTION EXPERIMENTAL. Specimens. Extraction

Application Note for Gentian Cystatin C Immunoassay on. Cobas c501 1 (Optimised Volumes II), Roche Diagnostics 1 v06-september 2010

Appendix A - Test Methods Method 301--Field Validation of Pollutant Measurement Methods from Various Waste Media

ALLOWAY METHOD OUTLINE

VOTING DRAFT STANDARD

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD TO DETERMINE CINITAPRIDE HYDROGEN TARTARATE IN BULK AND PHARMACEUTICAL FORMULATION

TNI V1M Standard Update Guidance on Detection and Quantitation

USEPA CONTRACT LABORATORY PROGRAM NATIONAL FUNCTIONAL GUIDELINES FOR ORGANIC DATA REVIEW

Analyst Software. Peptide and Protein Quantitation Tutorial

Clinical Toxicology. Biomass Component Extraction: The uneaten cooked plant specimen was prepared for

RPR 29 CYCLOTRON RADIOCHEMISTRY LABORATORY

Certificate of Analysis

Stability Studies to Support PET Drug Applications

ICH guideline M10 on bioanalytical method validation

Liquid storage: Holds the solvent which is going to act as the mobile phase. Pump: Pushes the solvent through to the column at high pressure.

ASB Standard 036, First Edition Standard Practices for Method Validation in Forensic Toxicology

Quantitation of a target protein in crude samples using targeted peptide quantification by Mass Spectrometry

13-15 FEB King Abdulaziz University Faculty of Pharmacy

6 x 5 Ways to Ensure Your LC-MS/MS is Healthy

Version 1.0 October 2007

Uncontrolled Copy. Table of Contents. 1. Introduction and Principle of Assay Specimens Reagents and Materials...

The CLN Focus on Mass Spectrometry is supported by Waters Corporation

Fast and Reliable Method for the Analysis of Methylmalonic Acid from Human Plasma

MANUAL FOR THE CERTIFICATION OF LABORATORIES ANALYZING ENVIRONMENTAL SAMPLES FOR THE IOWA DEPARTMENT OF NATURAL RESOURCES

Minimizing Commercial Influence on Education Policy

Transcription:

Wednesday April 5, 2017 2pm COLA Mass Spec Criteria Kathy Nucifora, MPH, MT(ASCP) COLA, Accreditation Division Director Columbia, MD DESCRIPTION: Kathy Nucifora, COLA Accreditation Division Director, will present the COLA requirements for laboratories performing LC/MS/MS by discussing each of the COLA MSPEC criteria. About the Speaker: Kathy received her Bachelor s degree in Medical Technology from Ball State University, and her Master of Public Health (MPH) Degree from Wichita State University. Kathy has a wide range of experience managing clinical laboratories, including large and small POLs, and large and small hospital laboratories. She has also taught Clinical Chemistry and Urinalysis in the MLT program at the Community College of Baltimore County, and has lectured on many relevant laboratory topics to a variety of audiences. Kathy served on the CLSI workgroup that developed companion products for Evaluation Protocol 23 (EP23), and currently serves on the Editorial Review Board for Lab Tests Online. Kathy has been the Accreditation Division Manager at COLA since 2009, and she has since been promoted to Director of Accreditation. CRI and COLA do not endorse, directly or indirectly, the presentations given at this conference or the products or services provided by the exhibiting vendors. Presentations are intended to be free of bias. The use of any particular product is for demonstration purposes only, and does not imply an endorsement of the product by the presenter or the sponsors of the symposium. 2017 CRI

COLA requirements for LC/MS/MS APRIL 2017 Check tuning MSPEC 1 Does the laboratory have a written procedure, approved by the Laboratory Director, for check tuning each mass spectrometer which includes acceptance parameters and frequency requirements? At a minimum, the lab must perform electronic tuning at the frequency recommended by the manufacturer. The procedure should include the indicators that would constitute the need for a check tune beyond the established frequency. Tuning must be documented and maintained.

MSPEC 2 Mass calibration Does the laboratory have a written procedure, approved by the Laboratory Director, for the performance of mass calibration, which includes acceptance parameters and frequency requirements? Mass calibration should be performed minimally at the frequency specified by the manufacturer, if applicable, or for troubleshooting purposes when QC or other routine quality checks do not fall within established parameters. The procedure should include the indicators that would constitute the need for a mass calibration beyond the established frequency. Mass calibration must be documented and maintained. Ion suppression MSPEC 3 For each reportable analyte, has the laboratory evaluated the specimen matrix for ion suppression? As part of the method validation for each analyte, interference caused by ion suppression should be evaluated using spiked standards comparisons. The Laboratory Director must review the ion suppression studies to evaluate standards recovery of and decide if further studies are necessary. Adjustments to procedures for identification and quantification of the target analyte must be documented. Ion suppression studies must be repeated if there is a change in specimen type for any given analyte.

Internal Standard MSPEC 3.1 (NEW) Are target specific isotopically labeled internal standards used? Or if selected surrogates are used as internal standards are these surrogates similar to the target analyte in physicochemical properties? The internal standard is critical to the mass spectrometry technique. It is the basis for correcting various sample specific variables such as recovery and matrix effects. To be so used, the internal standards must respond as the target during the total testing process, from sample prep trough chromatography and spectrometry. The optimal internal standard is an isotope of the target analyte, identical in all chemical and analytical aspects but with a different mass clearly distinguished by mass spectroscopy. Therefore, isotopes of the target analytes are strongly encouraged to be used as internal standards. MSPEC 3.1 (continued) Internal Standard The internal standard for each analyte is commonly a stable isotope-labeled analog of the measured analyte. A co-eluting isotopically labeled internal standard would correct for sample specific anomalies in chromatography and mass spectrometry. For example, isotopically labeled internal standards correct for target specific variables and matrix effects such as ion suppression or enhancement. To fully correct for chromatographic variables and matrix effects, ion suppression/enhancement the internal standard must elute from the LC column at the same or nearly the same retention time as the target analyte. Special care must be taken if the internal standard used is not an isotope of the target analyte.

Identification criteria MSPEC 4 Does the laboratory procedure for each analyte reported using mass spectrometry include specific peak identification criteria approved by the Laboratory Director? The procedure must include the laboratory s criteria for evaluating the mass spec chromatogram, based upon credible reference materials and the laboratory s own validation studies. Identification criteria may include elution time, qualifier/quantifier ion ratios limits, abundance, calibration, S/N ratio, quality control or other laboratory specific parameters. Identification criteria specific to a particular reported analyte must be defined. Signal to noise ratio MSPEC 4.1 (NEW) Do the peak identification criteria for each reported analyte include a review of the Signal to Noise (S/N) ratio with a defined minimum S/N of 10:1 or greater, for both the quantifier and qualifier ions, when used to confirm the presence of an analyte? The capability of the instrument to detect a signal above background noise is critical to low end sensitivity of the assay method.

Chromatogram review MSPEC 5 Are all sample chromatograms reviewed for accuracy prior to release of the patient report? Chromatograms must be reviewed for accuracy by qualified high complexity testing personnel who have documented training and competency assessment. Qualitative QC MSPEC 6 If the laboratory uses a cutoff value for reporting positive or negative, do the quality control materials used for each analyte include one with an expected result that is below the positive cutoff value and one with an expected result that is above the positive cutoff value? In order for QC to be relevant, materials that challenge the positive cutoff or decision point, on both sides, should be used. This criterion also applies to other methods that have a positive cutoff value.

MSPEC 6.1 (NEW) QC Are a minimum of a blank and two levels of QC included with each analytic run? To account for changes during the run, it is good laboratory practice to run a blank and two levels at the beginning AND two levels at the end of each analytical run. For large runs (>50 samples), two levels of QC in the middle of the run is useful. Technical Supervisor MSPEC 7 Does the person designated as Technical Supervisor for the mass spectrometry have the CLIA-defined qualifications for the position plus at least one year of training and/or experience specifically in mass spectrometry? The Technical Supervisor is a critical position in the mass spectrometry laboratory. Due to the unique expertise required for accurate results in a mass spec lab, COLA requires that the Technical Supervisor have specific documented training or experience related to the clinical use of mass spectrometry. In order to meet the CLIA-defined responsibility of competency assessment, the Technical Supervisor must be well-versed in the day to day operation and critical review of mass spec data.

MSPEC 8 (NEW) Run-to run retention time monitoring Is retention time difference between the quantitation ion and the internal standard monitored for each analyte from run-to-run? The laboratory must establish acceptability thresholds for run-to-run retention time variability, and take corrective action when the established acceptability thresholds are exceeded. For accurate peak identification, retention time variance, relative to the internal standard must be monitored. Factors that affect the retention time include temperature, mobile phase solvents, and chromatography column age. Carryover MSPEC 9 (NEW) Does the laboratory have a written procedure for performing a carryover study and for identifying and correcting possible carryover errors? This is commonly done by requiring that a blank sample be injected and analyzed following a sample with a high concentration of the measured analyte. The laboratory procedure defines limits of acceptability and appropriate action(s) when carryover is suspected and exceeds acceptable limits.

MSPEC 10 (NEW) Method comparisons As part of the method validation, has the laboratory evaluated each mass spec analyte using comparison testing with another CLIA certified laboratory performing mass spec analyses? The laboratory must document comparison studies for specimens using another CLIA certified lab that tests for the same analyte(s). Specimens used in the comparison studies must included, at a minimum, a blank (target analyte absent) and two specimens in which the target analyte is present one with a quantitative value in the lower half of the reportable range and one with a quantitative value in the upper half of the reportable range. MSPEC 10 (continued) Method comparisons The Lab Director must define acceptable limits for bias, and any discrepant results should be investigated and explained by the LD or TS. There may also be rare instances when another CLIA certified lab may not be available for comparison studies. In these rare instances, labs must document rationale for not completing these studies and the LD must approve these actions. For rarely detected analytes, it is acceptable to use spiked samples for comparison testing. Relative analytical costs and shipping fees are not appropriate reasons for excluding comparison studies.

Specimen integrity MSPEC 11 (NEW) For each analyte tested using mass spectrometry, has the laboratory established requirements for specimen acceptability, including storage temperature and specimen age requirements, prior to testing? Specimen stability studies for both primary specimens and extractions must be included with the lab method validation study. Test procedures must include criteria for specimen rejection, including specimen transport, storage, and age limitation criteria validated by the lab and approved by the Laboratory Director. Contact information info@cola.org 800-981-9883 www.colacentral.com